Mepsevii is indicated for the treatment of non-neurological manifestations of Mucopolysaccharidosis VII (MPS VII; Sly syndrome).
Vestronidase alfa
Alglucosidase alfa
Avalglucosidase alfa
Acemannan
Voglibose
Mucrocetin
Bovhyaluronidase azoximer
Susoctocog alfa